T8	Exp 129 145	the implications
T9	Exp 305 350	the simian immunodeficiency virus (SIV) model
T10	Exp 566 570	that
T11	Exp 630 643	the emergence
T12	Exp 680 684	that
T13	Exp 766 786	the safety phenotype
T14	Exp 810 812	we
T15	Exp 929 931	We
T16	Exp 974 982	the cDNA
T17	Exp 1068 1082	the nef region
T18	Exp 1234 1236	We
T19	Exp 1341 1363	its stable maintenance
T20	Exp 1258 1262	that
T21	Exp 1263 1277	the phenotypic
T22	Exp 1530 1541	this degree
T23	Exp 1626 1630	that
T24	Exp 1663 1667	when
T25	Exp 1686 1701	the replication
T26	Exp 1732 1746	These findings
R5	Coref Anaphora:T12 Antecedent:T27
R6	Coref Anaphora:T20 Antecedent:T28
R7	Coref Anaphora:T19 Antecedent:T29
R8	Coref Anaphora:T23 Antecedent:T30
T1	Protein 103 116	IkappaB-alpha
T2	Protein 420 423	nef
T3	Protein 1043 1056	IkappaB-alpha
T4	Protein 1072 1075	nef
T5	Protein 1101 1114	IkappaB-alpha
T6	Protein 1313 1326	IkappaB-alpha
T7	Protein 1579 1592	IkappaB-alpha
T27	Exp 665 679	New strategies
T28	Exp 1245 1257	formal proof
T29	Exp 1330 1333	36A
T30	Exp 1607 1625	proof-of-principle
